• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 0.32% Nasdaq down 0.01%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.32% Nasdaq down 0.01%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    No such ticker symbol: APHB.PKTry Symbol Lookup
    Jul 31 8.16 +0.31 +3.95% 7.82 8.19 8,264,633 3,362,890 1.54B Sparkline Chart Chart, News, Stats, Options, Board
    No such ticker symbol: AVIITry Symbol Lookup
    Jul 31 2.28 -0.06 -2.56% 2.26 2.39 96,584 218,362 52.45M Sparkline Chart Chart, News, Stats, Options, Board
    Jul 31 2.72 -0.04 -1.45% 2.70 2.79 1,835,173 1,014,210 176.86M Sparkline Chart Chart, News, Stats, Options, Board
    No such ticker symbol: URGP.PKTry Symbol Lookup
    Jul 31 0.644 +0.014 +2.22% 0.61 0.645 160,277 1,148,600 58.889M Sparkline Chart Chart, News, Stats, Options, Board
    No such ticker symbol: VRNMTry Symbol Lookup
    {"s" : "aria,clsn,cytr,vicl","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Saturday August 1, 2015
    10-Q for Vical, Inc. Company Spotlight08:09pm EDT
    Thursday July 30, 2015
    Celgene Corp. Earnings Analysis: By the Numbers at Capital Cube08:53am EDT
    Vical reports 2Q loss AP07:01am EDT
    VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online06:32am EDT
    Vical Reports Second Quarter 2015 Financial Results and Progress in Key Development Programs GlobeNewswire06:30am EDT
    Wednesday July 29, 2015
    Who Really Won in the PDL and Ariad Royalty Deal? at 24/7 Wall St.12:09pm EDT
    ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financ EDGAR Online07:45am EDT
    ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma Business Wire07:35am EDT
    PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals PR Newswire07:35am EDT
    Monday July 27, 2015
    ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online04:40pm EDT
    Friday July 24, 2015
    Is Ariad Pharmaceuticals a Cheap Stock? at Motley Fool06:01pm EDT
    ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online04:08pm EDT
    CytRx Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire11:00am EDT
    Thursday July 23, 2015
    The Biotech Rocket is Running Out of Fuel: Three Stocks to Keep You Soaring - Broad Street Alerts Accesswire07:00am EDT
    Vical Announces News Release and Conference Call Schedule for Second Quarter 2015 Financial Results GlobeNewswire06:30am EDT
    Wednesday July 22, 2015
    ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results Business Wire07:35am EDT
    Tuesday July 21, 2015
    CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events EDGAR Online05:08pm EDT
    CytRx Announces Pricing of Public Offering of 9.1 Million Shares of Common Stock PR Newswire08:45am EDT
    Monday July 20, 2015
    CYTRX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online04:14pm EDT
    CytRx Announces Proposed Public Offering of Common Stock PR Newswire04:01pm EDT
    Thursday July 16, 2015
    Celsion Corp. (CLSN) in Focus: Stock Jumps 5.4% - Tale of the Tape Zacks09:18am EDT
    Wednesday July 15, 2015
    One Reason Celsion (CLSN) Stock Is Soaring at TheStreet10:29am EDT
    Coverage initiated on Celsion by Maxim Group Briefing.com05:28am EDT
    Tuesday July 7, 2015
    Celsion's Phase II Breast Cancer Study Interim Data Positive - Analyst Blog Zacks02:30pm EDT
    Monday July 6, 2015
    Celsion Announces Continuing Positive Data from Its Phase 2 DIGNITY Study in Breast Cancer PR Newswire08:00am EDT